Biocolloids Lab, Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo, São Paulo, Brazil.
Int J Nanomedicine. 2010 Apr 7;5:249-59. doi: 10.2147/ijn.s9035.
Mimicking nature is a powerful approach for developing novel lipid-based devices for drug and vaccine delivery. In this review, biomimetic assemblies based on natural or synthetic lipids by themselves or associated to silica, latex or drug particles will be discussed. In water, self-assembly of lipid molecules into supramolecular structures is fairly well understood. However, their self-assembly on a solid surface or at an interface remains poorly understood. In certain cases, hydrophobic drug granules can be dispersed in aqueous solution via lipid adsorption surrounding the drug particles as nanocapsules. In other instances, hydrophobic drug molecules attach as monomers to borders of lipid bilayer fragments providing drug formulations that are effective in vivo at low drug-to-lipid-molar ratio. Cationic biomimetic particles offer suitable interfacial environment for adsorption, presentation and targeting of biomolecules in vivo. Thereby antigens can effectively be presented by tailored biomimetic particles for development of vaccines over a range of defined and controllable particle sizes. Biomolecular recognition between receptor and ligand can be reconstituted by means of receptor immobilization into supported lipidic bilayers allowing isolation and characterization of signal transduction steps.
模仿自然是开发新型基于脂质的药物和疫苗递送系统的有力方法。在这篇综述中,将讨论基于天然或合成脂质的仿生组装体,这些组装体本身或与二氧化硅、乳胶或药物颗粒结合。在水中,脂质分子自组装成超分子结构已经得到了很好的理解。然而,它们在固体表面或界面上的自组装仍然知之甚少。在某些情况下,疏水性药物颗粒可以通过脂质吸附在药物颗粒周围作为纳米胶囊分散在水溶液中。在其他情况下,疏水性药物分子作为单体附着在脂质双层片段的边界上,提供了在低药物-脂质摩尔比下在体内有效的药物制剂。阳离子仿生颗粒为生物分子的吸附、呈现和靶向提供了合适的界面环境。因此,通过定制的仿生颗粒可以有效地呈现抗原,从而开发出一系列定义明确和可控的粒径的疫苗。通过将受体固定在支撑脂质双层中,可以重建受体和配体之间的生物分子识别,从而可以分离和表征信号转导步骤。